NCT00237419 - Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis | Biotech Hunter

Enrollment

149

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

April 30, 2011

Conditions

Ankylosing Spondylitis

Interventions

DRUG

infliximab

Infliximab infusions 5 mg/kg body-weight each 6 to 8 weeks

Trial Locations (15)

3000

RECRUITING

University Hospital Leuven, Leuven

9000

RECRUITING

Universitair Ziekenhuis, Afdeling Rheumatologie, Ghent

10117

RECRUITING

Charite Mitte, Berlin

12200

RECRUITING

Charite Klinikum Steglitz, Berlin

44652

RECRUITING

Rheumazentrum Ruhrgebiet, Herne

80336

RECRUITING

Ludwigs-Maximilian-Universität, München

Unknown

RECRUITING

Erasme University Hospital, Brussels

RECRUITING

Limburg University Centre, Diepenbeek

RECRUITING

Groupe Hopitalier Cochin, Paris

RECRUITING

Universitat R. Descartes, Hopital Cochin, Paris

00029HYKS

RECRUITING

University Central Hospital, Division of Rheumatology, Helsinki

1007MB

RECRUITING

Academic Ziekenhuis, Amsterdam

6202 AZ

RECRUITING

University Hospital Maastricht, Maastricht

CB2 QQ

RECRUITING

University of Cambridge/ Clin Med, Cambridge

LS2 9N2

RECRUITING

University of Leeds, Leeds